Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00005890 · ClinicalTrials.gov registry record · NA
Diagnostic Study of Adrenal Cortical Function in Children With Septic Shock
A NA study of Septic Shock, sponsored by National Center for Research Resources (NCRR).
- Completed
- Registry status
- NA
- Development phase
- 56
- Enrollment target
- 1
- Study location
NCT00005890: Completed NA study of Septic Shock, sponsored by National Center for Research Resources (NCRR).
NCT00005890 is a NA study of Septic Shock that has completed, run by National Center for Research Resources (NCRR). The registered enrollment target is 56 participants, below the 5,057-participant average among 24 other Septic Shock trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00005890, a NA study of Septic Shock, has completed, sponsored by National Center for Research Resources (NCRR).
- COMPLETED
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
- 1
- Study location
Study Summary
OBJECTIVES: I. Examine adrenal cortical function and the incidence of adrenal dysfunction in children with septic shock. II. Examine the mortality, length of stay in the PICU, and incidence of multiorgan failure in children with adrenal dysfunction and septic shock.
Conditions Studied
Interventions
- DRUG corticotropin
Study Locations (1)
Ohio
- Children's Hospital Medical Center - Cincinnati - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 1996-03 |
| Phase | NA |
What the finished NCT00005890 record still lists
NCT00005890 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 5,057-participant average among 24 other Septic Shock trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Septic Shock appearing as the primary indexed condition, and to 1 intervention - of which corticotropin is the first listed.
NCT00005890 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT00005890 about?
NCT00005890 is a clinical study titled "Diagnostic Study of Adrenal Cortical Function in Children With Septic Shock". OBJECTIVES: I. Examine adrenal cortical function and the incidence of adrenal dysfunction in children with septic shock. II. Examine the mortality, length of stay in the PICU, and incidence of multiorgan failure in children with adrenal dysfunction and septic shock.
What is the current status of trial NCT00005890?
This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 1996-03.
What conditions does trial NCT00005890 study?
This clinical trial studies the following conditions: Septic Shock.
What interventions are being tested in trial NCT00005890?
The interventions under investigation include: corticotropin (DRUG).
Who is sponsoring clinical trial NCT00005890?
This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00005890 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Septic Shock
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00005890's enrollment target sits among peer trials
56 16th of 24 higher than 9 of 24 other Septic Shock trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Septic Shock trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
External Drainage of Thoracic Duct Lymph to Reduce Inflammatory Cytokines in Septic Shock Patients
RECRUITING · NA
-
Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis
RECRUITING · NA
-
Assessment for Implementation Methods in Sepsis
RECRUITING · NA
-
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
RECRUITING · NA
-
Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Endotoxemic Septic Shock in a Randomized, Open-Label Study
ACTIVE NOT RECRUITING · NA
-
Blood Purification for the Treatment of Pathogen Associated Shock
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia